Wedbush Starts Surface Oncology (SURF) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts SURF Hot Sheet
Price: $1.07 --0%
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Join SI Premium – FREE
Wedbush analyst Robert Driscoll initiates coverage on Surface Oncology (NASDAQ: SURF) with a Outperform rating and a price target of $12.00.
For an analyst ratings summary and ratings history on Surface Oncology click here. For more ratings news on Surface Oncology click here.
Shares of Surface Oncology closed at $5.46 yesterday.
You May Also Be Interested In
- Citi initiates ATI Inc. coverage with Buy rating, $229 target
- H.C. Wainwright Assumes MiNK Therapeutics (INKT) at Buy
- CLSA Starts Kakaku.com Inc. (2371:JP) (KKKUF) at Outperform (2)
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
